# Tofacitinib

NDC: 51991-963
Generic name: Tofacitinib Citrate
Labeler / Manufacturer: Breckenridge Pharmaceutical, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20260603

FDA application: ANDA209633

## Active ingredients

- TOFACITINIB CITRATE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51991-963"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51991-963
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c963c610-52e5-43ab-aac6-3f7e5341b764